Migraine Therapy

NuPathe Has Received a Notice
May 29, 2013
NuPathe has received a notice for additional US patent allowance to cover methods for treating migraine patients using an iontophoretic patch containing a triptan without irritating the patient's skin. Expected to be issued in the next ...

Tags: Migraine Therapy, Medicine
The FDA Has Issued a Complete Response Letter to Allergan's New Drug Application
Apr 22, 2013
The US Food and Drug Administration (FDA) has issued a complete response letter (CRL) to Allergan's New Drug Application (NDA) for Levadex (dihydroergotamine) inhalation aerosol for the acute treatment of migraine in adults. In addition ...

Tags: Migraine Therapy, Medicine
FDA Has Approved Mylan Pharmaceuticals' Abbreviated New Drug Applications
Jan 4, 2013
The US Food and Drug Administration (FDA) has approved Mylan Pharmaceuticals' abbreviated new drug applications (ANDA) for the generic equivalents to Merck's Maxalt MLT tablets and Maxalt tablets. Rizatriptan Benzoate orally ...

Tags: US, FDA, Mylan Pharmaceuticals, ANDA, Maxalt MLT tablets, Maxalt tablets